Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis

BACKGROUND: This study compared the efficacy and tolerability of available direct-acting antiviral (DAA) regimens between individuals aged 60 years and older and younger patients in a real-life setting. Specifically, we aimed to provide evidence of the efficacy and safety of DAAs in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Huan, Zhang, Yaping, Zaongo, Silvere D., Liang, Jing, Gong, Xiaowen, Hu, Yue, Ma, Ping, Wang, Fengmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184475/
https://www.ncbi.nlm.nih.gov/pubmed/34164481
http://dx.doi.org/10.21037/atm-21-1297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184475/
https://www.ncbi.nlm.nih.gov/pubmed/34164481
http://dx.doi.org/10.21037/atm-21-1297

Ejemplares similares